$160 Million is the total value of CAXTON CORP's 44 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 217.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRDF | Buy | CARDIFF ONCOLOGY INC | $38,046,000 | +45.3% | 2,114,840 | +14.6% | 23.72% | -3.9% |
| MTEM | MOLECULAR TEMPLATES INC | $19,935,000 | -14.0% | 2,122,991 | 0.0% | 12.43% | -43.2% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $19,657,000 | +15.7% | 8,089,442 | 0.0% | 12.25% | -23.5% | |
| CTIC | Sell | CTI BIOPHARMA CORP | $12,075,000 | +30.2% | 3,749,890 | -13.1% | 7.53% | -13.9% |
| SCYX | Buy | SCYNEXIS INC | $11,279,000 | +206.5% | 1,474,370 | +76.7% | 7.03% | +102.6% |
| SRRA | SIERRA ONCOLOGY INC | $10,323,000 | +50.2% | 643,959 | 0.0% | 6.44% | -0.7% | |
| KALA | Buy | KALA PHARMACEUTICALS INC | $7,745,000 | +33.8% | 1,142,360 | +48.0% | 4.83% | -11.5% |
| GLD | Buy | SPDR GOLD TR | $7,341,000 | +63.5% | 41,161 | +62.3% | 4.58% | +8.1% |
| XL | New | XL FLEET CORP | $7,119,000 | – | 300,000 | +100.0% | 4.44% | – |
| RZLT | New | REZOLUTE INC | $5,087,000 | – | 424,243 | +100.0% | 3.17% | – |
| ADXN | Buy | ADDEX THERAPEUTICS LTDsponsored ads | $3,564,000 | +1573.2% | 265,940 | +1428.6% | 2.22% | +1005.5% |
| AJAX | New | AJAX I | $3,103,000 | – | 250,000 | +100.0% | 1.93% | – |
| LUXAU | New | LUX HEALTH TECH ACQUISITIONunit 11/30/2027 | $2,300,000 | – | 200,000 | +100.0% | 1.43% | – |
| MRACU | New | MARQUEE RAINE ACQUISITION COunit 12/01/2025 | $1,143,000 | – | 105,500 | +100.0% | 0.71% | – |
| BTWN | New | BRIDGETOWN HOLDINGS LTD | $1,125,000 | – | 72,688 | +100.0% | 0.70% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $972,000 | +5.8% | 79,048 | -30.0% | 0.61% | -30.0% |
| HMCOU | New | HUMANCO ACQUISITION CORPunit 12/08/2023 | $942,000 | – | 85,500 | +100.0% | 0.59% | – |
| ISEE | Sell | IVERIC BIO INC | $933,000 | -14.2% | 134,981 | -30.0% | 0.58% | -43.2% |
| FLACU | New | FRAZIER LIFESCIENCES ACQU COunit 12/09/2025 | $664,000 | – | 64,000 | +100.0% | 0.41% | – |
| SCOAU | New | SCION TECH GROWTH Iunit 12/17/2025 | $604,000 | – | 58,500 | +100.0% | 0.38% | – |
| PTMN | New | PORTMAN RIDGE FIN CORP | $571,000 | – | 299,088 | +100.0% | 0.36% | – |
| CDLX | New | CARDLYTICS INC | $410,000 | – | 2,869 | +100.0% | 0.26% | – |
| DIS | New | DISNEY WALT CO | $339,000 | – | 1,870 | +100.0% | 0.21% | – |
| PYPL | New | PAYPAL HLDGS INC | $297,000 | – | 1,267 | +100.0% | 0.18% | – |
| TDG | New | TRANSDIGM GROUP INC | $290,000 | – | 469 | +100.0% | 0.18% | – |
| CVNA | New | CARVANA COcl a | $287,000 | – | 1,198 | +100.0% | 0.18% | – |
| FICO | New | FAIR ISAAC CORP | $282,000 | – | 552 | +100.0% | 0.18% | – |
| MA | New | MASTERCARD INCORPORATEDcl a | $281,000 | – | 787 | +100.0% | 0.18% | – |
| V | New | VISA INC | $272,000 | – | 1,244 | +100.0% | 0.17% | – |
| INTU | New | INTUIT | $270,000 | – | 710 | +100.0% | 0.17% | – |
| NFLX | New | NETFLIX INC | $265,000 | – | 491 | +100.0% | 0.16% | – |
| MDLZ | New | MONDELEZ INTL INCcl a | $255,000 | – | 4,360 | +100.0% | 0.16% | – |
| MSFT | New | MICROSOFT CORP | $254,000 | – | 1,142 | +100.0% | 0.16% | – |
| MCO | New | MOODYS CORP | $250,000 | – | 863 | +100.0% | 0.16% | – |
| CHTR | New | CHARTER COMMUNICATIONS INC Ncl a | $251,000 | – | 379 | +100.0% | 0.16% | – |
| GOOG | New | ALPHABET INCcap stk cl c | $246,000 | – | 140 | +100.0% | 0.15% | – |
| CRM | New | SALESFORCE COM INC | $237,000 | – | 1,064 | +100.0% | 0.15% | – |
| FB | New | FACEBOOK INCcl a | $235,000 | – | 860 | +100.0% | 0.15% | – |
| AMT | New | AMERICAN TOWER CORP NEW | $231,000 | – | 1,027 | +100.0% | 0.14% | – |
| SPGI | New | S&P GLOBAL INC | $230,000 | – | 700 | +100.0% | 0.14% | – |
| WHR | New | WHIRLPOOL CORP | $227,000 | – | 1,259 | +100.0% | 0.14% | – |
| HLXA | New | HELIX ACQUISITION CORP | $182,000 | – | 16,009 | +100.0% | 0.11% | – |
| BTWNW | New | BRIDGETOWN HOLDINGS LTD*w exp 09/30/202 | $175,000 | – | 39,773 | +100.0% | 0.11% | – |
| MEIP | Sell | MEI PHARMA INC | $132,000 | -75.9% | 50,000 | -71.5% | 0.08% | -84.1% |
| PSTHWS | Exit | PERSHING SQUARE TONTINE HLDG*w exp 07/24/202 | $0 | – | -7,485 | -100.0% | -0.05% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -26,590 | -100.0% | -0.17% | – |
| CCIVU | Exit | CHURCHILL CAPITAL CORP IVunit 99/99/9999 | $0 | – | -62,500 | -100.0% | -0.59% | – |
| PSTH | Exit | PERSHING SQUARE TONTINE HLDG | $0 | – | -67,369 | -100.0% | -1.44% | – |
| Exit | GARRISON CAP INC | $0 | – | -1,164,061 | -100.0% | -4.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLECULAR TEMPLATES INC | 24 | Q2 2023 | 30.7% |
| STRONGBRIDGE BIOPHARMA PLC | 22 | Q3 2021 | 73.1% |
| GARRISON CAP INC | 18 | Q3 2020 | 9.9% |
| BERKSHIRE HATHAWAY INC DEL | 17 | Q3 2019 | 5.8% |
| EIGER BIOPHARMACEUTICALS INC | 17 | Q3 2022 | 1.7% |
| AGILE THERAPEUTICS INC | 16 | Q1 2018 | 55.5% |
| KALA PHARNACEUTICALS INC | 16 | Q4 2021 | 17.6% |
| CM FIN INC | 16 | Q1 2019 | 7.8% |
| SYNTA PHARMACEUTICALS CORP | 15 | Q2 2016 | 99.9% |
| CTI BIOPHARMA CORP | 14 | Q4 2021 | 8.7% |
View CAXTON CORP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Addex Therapeutics Ltd. | February 14, 2023 | 718,849 | 0.9% |
| Cardiff Oncology, Inc. | February 14, 2023 | 983,607 | 2.2% |
| Rezolute, Inc. | February 14, 2023 | 1,860,518 | 5.0% |
| Xeris Biopharma Holdings, Inc. | February 14, 2023 | 5,973,324 | 4.4% |
| CTI BIOPHARMA CORP | February 14, 2022 | 2,239,300 | 2.3% |
| Sierra Oncology, Inc. | February 14, 2022 | 1,119,322 | 7.0% |
| Strongbridge Biopharma plcSold out | January 05, 2022 | 0 | 0.0% |
| SUNESIS PHARMACEUTICALS INCSold out | February 16, 2021 | 0 | 0.0% |
| Alcentra Capital Corp | February 14, 2020 | 1,005,000 | 7.8% |
| Garrison Capital Inc. | February 14, 2020 | 1,223,096 | 7.6% |
View CAXTON CORP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View CAXTON CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.